Metformin selectively affects human glioblastoma tumor-initiating cell viability
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin selectively affects human glioblastoma tumor-initiating cell viability
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 1, Pages 145-156
Publisher
Informa UK Limited
Online
2012-12-27
DOI
10.4161/cc.23050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.
- (2015) Leonidas Platanias et al. Oncotarget
- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line
- (2012) Sara R Martins-Neves et al. BMC CANCER
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
- (2012) C R Garrett et al. BRITISH JOURNAL OF CANCER
- Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma
- (2012) Roberto E Favoni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
- (2012) Eleftherios Sachlos et al. CELL
- Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation
- (2012) Arron Sikka et al. CELL CYCLE
- Rejuvenating regeneration: Metformin activates endogenous adult stem cells
- (2012) JAVIER MENENDEZ et al. CELL CYCLE
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
- (2012) Jing Wang et al. Cell Stem Cell
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
- (2012) K. Kemper et al. CLINICAL CANCER RESEARCH
- The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells
- (2012) Tullio Florio et al. DRUG DISCOVERY TODAY
- In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
- (2012) Zhan Qu et al. HEPATOLOGY RESEARCH
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
- (2012) Guofang Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells
- (2012) Yang Hong et al. NEUROSCIENCE LETTERS
- Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
- (2012) W-Y Shi et al. Cell Death & Disease
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution
- (2011) Philippe Metellus et al. ANNALS OF SURGICAL ONCOLOGY
- Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets
- (2011) Federica Barbieri et al. BIOCHEMICAL PHARMACOLOGY
- Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin?
- (2011) RE Kast et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature
- (2011) Roberto Würth et al. JOURNAL OF NEUROIMMUNOLOGY
- Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties
- (2011) Yuanyuan Ma et al. PLoS One
- Diabetes and Cancer
- (2011) Annamaria Colao et al. Frontiers in Endocrinology
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- (2010) Alejandro Vazquez-Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
- (2010) Begoña Martin-Castillo et al. CELL CYCLE
- Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
- (2010) B. Campos et al. CLINICAL CANCER RESEARCH
- Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
- (2010) R. E. Favoni et al. CURRENT CANCER DRUG TARGETS
- Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
- (2010) Marc C Chamberlain Expert Review of Neurotherapeutics
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
- (2009) K. Kisfalvi et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors
- (2009) Fabrizio Griffero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
- (2008) M. Zakikhani et al. Cancer Prevention Research
- Overexpression of Stromal Cell-Derived Factor 1 and Its Receptor CXCR4 Induces Autocrine/Paracrine Cell Proliferation in Human Pituitary Adenomas
- (2008) F. Barbieri et al. CLINICAL CANCER RESEARCH
- Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
- (2008) C. Algire et al. ENDOCRINE-RELATED CANCER
- Epidermal Growth Factor Plays a Crucial Role in Mitogenic Regulation of Human Brain Tumor Stem Cells
- (2008) Akio Soeda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
- (2008) Kyeung Min Joo et al. LABORATORY INVESTIGATION
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Glioma Formation, Cancer Stem Cells, and Akt Signaling
- (2008) Dolores Hambardzumyan et al. Stem Cell Reviews and Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started